第一作者机构：[1]Fourth Hosp Hebei Med Univ, Shijiazhuang, Hebei, Peoples R China
推荐引用方式(GB/T 7714)：
Liu Yunjiang,Cao Miao,Liu Yueping,et al.A trail of neoadjuvant recombinant human endostatin in combination with docetaxel, epirubicin, and cyclophosphamide in breast cancer patients[J].JOURNAL OF CLINICAL ONCOLOGY.2016,34(15):doi:10.1200/JCO.2016.34.15_suppl.e12033.
APA：
Liu, Yunjiang,Cao, Miao,Liu, Yueping&Zhang, Xiangmei.(2016).A trail of neoadjuvant recombinant human endostatin in combination with docetaxel, epirubicin, and cyclophosphamide in breast cancer patients.JOURNAL OF CLINICAL ONCOLOGY,34,(15)
MLA：
Liu, Yunjiang,et al."A trail of neoadjuvant recombinant human endostatin in combination with docetaxel, epirubicin, and cyclophosphamide in breast cancer patients".JOURNAL OF CLINICAL ONCOLOGY 34..15(2016)
医学